Patten & Patten Inc Pfizer Inc Transaction History

Patten & Patten Inc

  • $1.43 Billion
  • Q3 2024

A detailed history of Patten & Patten Inc transactions in Pfizer Inc stock. As of the latest transaction made, Patten & Patten Inc holds 89,182 shares of PFE stock, worth $2.35 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
89,182
Previous 78,227 14.0%
Holding current value
$2.35 Million
Previous $2.19 Million 17.92%
% of portfolio
0.18%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$27.7 - $31.39 $303,453 - $343,877
10,955 Added 14.0%
89,182 $2.58 Million
Q2 2024

Aug 13, 2024
BUY
$25.26 - $29.6 $184,625 - $216,346
7,309 Added 10.31%
78,227 $2.19 Million
Q1 2024

May 10, 2024
SELL
$25.89 - $29.73 $347,883 - $399,482
-13,437 Reduced 15.93%
70,918 $1.97 Million
Q4 2023

Jan 23, 2024
SELL
$26.13 - $33.94 $253,696 - $329,523
-9,709 Reduced 10.32%
84,355 $2.43 Million
Q3 2023

Oct 27, 2023
SELL
$32.09 - $37.51 $53,847 - $62,941
-1,678 Reduced 1.75%
94,064 $3.12 Million
Q2 2023

Jul 14, 2023
BUY
$36.12 - $41.79 $123,096 - $142,420
3,408 Added 3.69%
95,742 $3.51 Million
Q1 2023

Apr 25, 2023
SELL
$39.39 - $51.28 $204,276 - $265,938
-5,186 Reduced 5.32%
92,334 $3.77 Million
Q4 2022

Feb 01, 2023
SELL
$41.75 - $54.5 $148,546 - $193,911
-3,558 Reduced 3.52%
97,520 $5 Million
Q3 2022

Oct 19, 2022
BUY
$43.76 - $53.42 $10,283 - $12,553
235 Added 0.23%
101,078 $4.42 Million
Q2 2022

Aug 02, 2022
SELL
$46.53 - $55.17 $31,268 - $37,074
-672 Reduced 0.66%
100,843 $5.29 Million
Q1 2022

Apr 25, 2022
SELL
$45.75 - $56.69 $12,764 - $15,816
-279 Reduced 0.27%
101,515 $5.26 Million
Q4 2021

Jan 26, 2022
BUY
$41.32 - $61.25 $123,174 - $182,586
2,981 Added 3.02%
101,794 $6.01 Million
Q3 2021

Oct 22, 2021
SELL
$39.25 - $50.42 $13,619 - $17,495
-347 Reduced 0.35%
98,813 $4.25 Million
Q2 2021

Jul 13, 2021
SELL
$35.91 - $40.68 $51,279 - $58,091
-1,428 Reduced 1.42%
99,160 $3.88 Million
Q1 2021

Apr 23, 2021
SELL
$33.49 - $37.77 $287,176 - $323,877
-8,575 Reduced 7.86%
100,588 $3.64 Million
Q4 2020

Jan 19, 2021
BUY
$33.47 - $42.56 $109,246 - $138,915
3,264 Added 3.08%
109,163 $4.02 Million
Q3 2020

Oct 08, 2020
BUY
$31.75 - $37.25 $92,932 - $109,030
2,927 Added 2.84%
105,899 $3.89 Million
Q2 2020

Jul 21, 2020
BUY
$30.12 - $36.54 $48,764 - $59,158
1,619 Added 1.6%
102,972 $3.37 Million
Q1 2020

Apr 16, 2020
SELL
$27.03 - $38.62 $303,438 - $433,548
-11,226 Reduced 9.97%
101,353 $3.31 Million
Q4 2019

Jan 13, 2020
SELL
$32.92 - $37.36 $389,311 - $441,819
-11,826 Reduced 9.51%
112,579 $4.41 Million
Q3 2019

Oct 15, 2019
SELL
$32.49 - $42.13 $196,012 - $254,170
-6,033 Reduced 4.63%
124,405 $4.47 Million
Q2 2019

Jul 11, 2019
SELL
$36.98 - $41.52 $80,912 - $90,845
-2,188 Reduced 1.65%
130,438 $5.65 Million
Q1 2019

Apr 23, 2019
BUY
$37.5 - $41.2 $2,437 - $2,678
65 Added 0.05%
132,626 $5.63 Million
Q4 2018

Jan 17, 2019
SELL
$38.47 - $43.86 $36,777 - $41,930
-956 Reduced 0.72%
132,561 $5.79 Million
Q3 2018

Oct 17, 2018
SELL
$34.47 - $41.81 $112,716 - $136,718
-3,270 Reduced 2.39%
133,517 $5.88 Million
Q2 2018

Jul 18, 2018
SELL
$32.98 - $35.16 $351,302 - $374,524
-10,652 Reduced 7.22%
136,787 $4.96 Million
Q1 2018

Apr 20, 2018
SELL
$31.91 - $37.02 $75,754 - $87,885
-2,374 Reduced 1.58%
147,439 $5.23 Million
Q4 2017

Jan 22, 2018
SELL
$33.26 - $35.29 $201,289 - $213,575
-6,052 Reduced 3.88%
149,813 $5.43 Million
Q3 2017

Oct 12, 2017
BUY
$31.0 - $34.15 $4.83 Million - $5.32 Million
155,865
155,865 $5.56 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email